Concepedia

Publication | Open Access

CD34+/CD38- stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin

DOIFull Paper Access

66

Citations

28

References

2011

Year

Harald Herrmann, Sabine Cerny‐Reiterer, Karoline V. Gleixner, K. Blatt, Susanne Herndlhofer, Werner Rabitsch, Eliézer Jäger, Gerlinde Mitterbauer‐Hohendanner, Berthold Streubel, Edgar Selzer,
Haematologica

Abstract

CD33 is expressed abundantly on immature CD34(+)/CD38(-) stem cells and may serve as a stem cell target in chronic myeloid leukemia.

References

YearCitations

Page 1